Press-release for stocks in the information sector related to trial

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Information tags : Trial

save search

CGNT EQUITY ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cognyte Software Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGNT
Published: 2023-03-05 (Crawled : 00:00) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| -15.41% | O: -13.71% H: 14.52% C: 14.52%
ARBK | $1.47 -0.68% -0.68% 230K

|

| -11.66% | O: -3.68% H: 8.28% C: 6.37%
CGNT | $6.54 -1.51% -1.53% 290K

|

| 75.2% | O: 0.26% H: 0.26% C: -4.43%
trial software deadline

ENVX IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Enovix Corporation Investors to Secure Counsel Before Important March 7 Deadline in Securities Class Action - ENVX
Published: 2023-02-27 (Crawled : 21:00) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| -12.85% | O: 12.12% H: 0.0% C: -10.81%
ARBK | $1.47 -0.68% -0.68% 230K

|

| -8.28% | O: 1.91% H: 7.5% C: 6.25%
ENVX S | $6.01 -9.35% -10.32% 13M

|

| -18.3% | O: 0.35% H: 9.52% C: 7.08%
trial corporation deadline

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Argo Blockchain plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARBK
Published: 2023-02-26 (Crawled : 00:00) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| -13.01% | O: -2.36% H: 7.5% C: 2.23%
ARBK | $1.47 -0.68% -0.68% 230K

|

| -12.73% | O: -2.42% H: 4.66% C: -2.48%
CCSI | $12.94 3.44% 3.32% 240K

|

| -71.6% | O: -0.09% H: 0.69% C: -4.19%
FATE | $5.04 -4.36% -4.56% 2.3M

|

Health Technology

| -7.08% | O: 1.73% H: 2.8% C: 2.04%
blockchain trial deadline

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Gemini Earn Program Investors to Secure Counsel Before Important Deadline in Securities Class Action Against Gemini Trust Company, LLC, Tyler Winklevoss, and Cameron Winklevoss
Published: 2023-02-13 (Crawled : 21:00) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| -15.41% | O: 5.88% H: 0.0% C: -11.17%
ARBK | $1.47 -0.68% -0.68% 230K

|

| -21.31% | O: -3.83% H: 10.23% C: -23.3%
FATE | $5.04 -4.36% -4.56% 2.3M

|

Health Technology

| -15.81% | O: -0.63% H: 2.83% C: -0.47%
program trial trust deadline

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Argo Blockchain plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARBK
Published: 2023-02-05 (Crawled : 20:20) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| Email alert Add to watchlist
FATE | $5.04 -4.36% -4.56% 2.3M

|

Health Technology

| Email alert Add to watchlist
ARBK | $1.47 -0.68% -0.68% 230K

|

| Email alert Add to watchlist
blockchain trial trusted deadline

ARBK EQUITY ALERT: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Argo Blockchain plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARBK
Published: 2023-01-29 (Crawled : 00:00) - prnewswire.com
ARBKF | $0.1412 103.42% 17K

|

| -24.32% | O: 5.26% H: 0.0% C: -2.8%
ARBK | $1.47 -0.68% -0.68% 230K

|

| -24.21% | O: -1.58% H: 2.14% C: -4.28%
FXLV | $0.0975 0.0% 5.1M

|

Arts, Entertainment, and Recrea...

| -96.9% | O: -3.87% H: 6.04% C: 3.69%
blockchain trial deadline

American CryoStem Announces FDA Approval of IND to Commence Phase I Clinical Trial for Long COVID/Post-Acute Sequelae of SARS-CoV-2 (PASC)
Published: 2023-01-06 (Crawled : 17:00) - biospace.com/
CRYO | $0.0001 0.0% 19K

|

| -99.89% | O: 26.98% H: 0.0% C: 0.0%
fda trial approval sars-cov-2

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Core Scientific, Inc. Investors with Losses to Secure Counsel Before Important January 13 Deadline in Securities Class Action - CORZ
Published: 2022-12-31 (Crawled : 00:20) - prnewswire.com
CORZ | $2.89 7.04% 6.57% 1.7M

|

| Email alert Add to watchlist
PHI | $22.75 -0.61% 0.0% 26K

|

| Email alert Add to watchlist
PHTCF | $20.83 48.2% 180

|

| Email alert Add to watchlist
trial deadline

TUYA INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Tuya Inc. (TUYA) Investors to Contact Firm's Attorneys, IPO-Related Securities Class Action Filed
Published: 2022-08-17 (Crawled : 14:00) - prnewswire.com
TUYA | $1.63 -1.81% 0.0% 180K

|

| -0.6% | O: 0.0% H: 1.2% C: -7.78%
trial

AUPH FINAL DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important June 14 Deadline in Securities Class Action - AUPH
Published: 2022-06-10 (Crawled : 22:00) - prnewswire.com
ARQQ | $0.507 2.42% 2.37% 420K

|

| Email alert Add to watchlist
AUPH | $4.81 -2.04% -2.08% 2.1M

|

Health Technology

| Email alert Add to watchlist
trial deadline

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - ARQQ, ARQQW, CENH, CENHU, CENHW
Published: 2022-06-10 (Crawled : 18:00) - prnewswire.com
ARQQ | $0.507 2.42% 2.37% 420K

|

| -91.97% | O: -2.8% H: 0.0% C: 0.0%
acquisition quantum trial deadline

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Arqit Quantum (ARQQ, CENH, CENHU, CENHW) Investors with Significant Losses to Contact Firm's Attorneys, Class Action Filed
Published: 2022-05-10 (Crawled : 14:00) - prnewswire.com
ARQQ | $0.507 2.42% 2.37% 420K

|

| -92.55% | O: -8.86% H: 0.0% C: 0.0%
quantum trial

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Mullen Automotive (MULN) with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations
Published: 2022-04-07 (Crawled : 14:00) - prnewswire.com
MULN | News | $2.9 0.69% 0.69% 680K

|

| 9.81% | O: -4.91% H: 3.97% C: -5.56%
automotive trial

Global Humanoid Robot Market (2021 to 2026) - by Application Type, Component Type, Motion Type, Industrial Vertical Type and Geography
Published: 2022-03-10 (Crawled : 17:00) - prnewswire.com
SFBQF | $11.94 -16.63% 2.4K

|

| -2.61% | O: 2.45% H: 1.91% C: -2.63%
SFTBF | $50.0287 1.64% 1.8K

|

| 19.98% | O: -1.51% H: 0.29% C: -2.08%
SFTBY | $25.03 -28.79% 660K

|

| 20.8% | O: -2.12% H: 0.39% C: -1.68%
application trial one

American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
Published: 2022-03-04 (Crawled : 12:00) - biospace.com/
CRYO | $0.0001 0.0% 19K

|

| -99.98% | O: 0.14% H: 0.0% C: -11.9%
america treatment trial cryo syndros

Mullen and Comau, a Leader in Industrial Automation, Team Up for Full-Scale Automotive Body Assembly at Mullen’s Tunica AMEC Facility
Published: 2022-01-31 (Crawled : 23:00) - globenewswire.com
MULN | News | $2.9 0.69% 0.69% 680K

|

| 2.46% | O: 2.11% H: 11.72% C: 11.03%
automotive trial

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TaskUs, Inc. (TASK) Investors to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations
Published: 2022-01-24 (Crawled : 15:00) - prnewswire.com
TASK 4 | $10.85 -0.64% -0.65% 170K

|

| -62.41% | O: -3.51% H: 6.92% C: 5.57%
trial

American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
Published: 2021-12-22 (Crawled : 08:00) - biospace.com/
CRYO | $0.0001 0.0% 19K

|

| -99.99% | O: 2.3% H: 8.55% C: 2.31%
trial cel cryo syndros

QCI and IPQ Partner on Novel Approach to Drive More Effective Clinical Trials and Diagnostic Outcomes
Published: 2021-07-13 (Crawled : 13:00) - globenewswire.com
QUBT | $0.7674 -3.59% -5.29% 580K

|

| Email alert Add to watchlist
clinical trials trial diagnostic

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M

|

ZCMD | $2.86 108.76% 52.1% 2.3M

|

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

|

Health Technology

ISPC | $0.437 105.16% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M

|

OST | $0.499 21.38% 45.26% 1.9M

|

XPON | News | $3.1 60.62% 37.74% 17M

|

TIRX | $0.7 44.39% 30.74% 58M

|

BNTC | News | $6.92 44.17% 30.64% 3.5M

|

Health Technology

GGE | $0.035 19.86% 29.3% 64M

|

Your saved searches

Save your searches and get alerts when important news are released.